Neoadjuvant Radiotherapy Followed by Surgery Compared with Surgery Alone in the Treatment of Retroperitoneal SarcomA: A Population-Based Comparison
Author(s) -
Benjamin T. Turner,
Laura Hampton,
Dan Schiller,
Lloyd A. Mack,
Connal Robertson-More,
H. Li,
May Lynn Quan,
Antoine BouchardFortier
Publication year - 2019
Publication title -
current oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.053
H-Index - 51
eISSN - 1718-7729
pISSN - 1198-0052
DOI - 10.3747/co.26.5185
Subject(s) - medicine , radiation therapy , surgery , proportional hazards model , exact test , univariate analysis , log rank test , survival analysis , sarcoma , cancer registry , population , multivariate analysis , cancer , environmental health , pathology
Retroperitoneal sarcoma (rps) encompasses a heterogeneous group of malignancies with a high recurrence rate after resection. Neoadjuvant radiotherapy (nrt) is often used in the hope of sterilizing margins and decreasing local recurrence after excision. We set out to compare local recurrence-free survival (lrfs) and overall survival (os) in patients treated with or without nrt before resection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom